Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

1 Guidance

2 The technology

3 The manufacturer's submission

4 Consideration of the evidence

5 Implementation

6 Recommendations for further research

7 Related NICE guidance

8 Review of guidance

Appendix A: Appraisal Committee members, guideline representatives and NICE project team

Appendix B: Sources of evidence considered by the Committee

Changes after publication

About this guidance

Select chapters and save as Word or PDF documents to print or share